FMTX - Forma Therapeutics GAAP EPS of -$0.93 beats by $0.15 May, 06 2022 07:13 AM Forma Therapeutics Holdings Inc. Forma Therapeutics press release (NASDAQ:FMTX): Q1 GAAP EPS of -$0.93 beats by $0.15. Cash and cash equivalents of $441.35M For further details see: Forma Therapeutics GAAP EPS of -$0.93 beats by $0.15